Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
Clinical trial NCT01792050 · COMPLETED
Trial details
- NCT number
- NCT01792050
- Sponsor
- NewLink Genetics Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-07-01
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.